Stefan Kaltenbacher takes over as Head of Healthcare from Bryan, Garnier & Co.
Paris/Munich — Stefan Kaltenbacher (56), photo, will head Bryan, Garnier and Co. ’s German-speaking investment banking activities in the life sciences sector (DACH region) from May 1, 2020. The new Managing Director has extensive general management experience in the pharmaceutical and medical technology industry as well as in private equity: Among other things, he was responsible for the Northern and Central European business of the medical technology company CareFusion (now part of Becton Dickinson), led the medical device sector of Johnson & Johnson in Germany and Austria, and was a member of Johnson & Johnson’s Strategy Team Europe. Prior to that, he worked in Paris and London as director for the international diagnostics division of Bayer AG. Most recently, as Managing Director of an owner-managed, independent M&A consultancy, he advised a large number of growth companies and established companies in the German-speaking region and was Senior Advisor to Deutsche Beteiligungsgesellschaft, Frankfurt, on its engagements in the life sciences sector.
“Particularly in the life sciences sector, industry experience is absolutely essential and we are delighted to have gained such an experienced industry expert for our German team,” emphasizes Falk Müller-Veerse, who as Partner is responsible for Bryan, Garnier & Co.’s business in the DACH region.
The healthcare industry is a central focus of the investment bank for technology companies, which was founded in Paris and London in 1996: Bryan, Garnier & Co. was involved in the successful Nasdaq IPO of biotech company BionTech, accompanied medical technology company Medartis to the Swiss stock exchange, and orchestrated a number of private financing rounds of life sciences start-ups with global investors, among others.
About Bryan, Garnier & Co
Bryan, Garnier & Co, founded in 1996 in Paris and London, is an investment bank focused on European growth companies with a presence in London, Paris, Munich, Stockholm, Oslo, Reykjavík, New York, Palo Alto and Shanghai. As an independent full-service investment bank, it offers comprehensive financing advice and support along the entire life cycle of its clients — from initial financing rounds to a potential sale or IPO with subsequent follow-up financing. The range of services includes equity analysis, equity sales and trading, private and public capital raising, and M&A advisory for growth companies and their investors. The focus is on the growth sectors of technology, healthcare, branded and consumer goods, and business services. Bryan Garnier is a registered broker and licensed with the FCA in Europe and FINRA in the US.